Contribution of direct and indirect recognition pathways to T cell alloreactivity

Journal of Experimental Medicine

Volumn 177, Issue 6, 1993, Pages 1643-1650

  Liu, Zhuoru ^a   Sun, Yu Kai ^a   Xi, Yu Ping ^a   Maffei, Antonella ^a   Reed, Elaine ^a   Harris, Paul ^a   Suciu Foca, Nicole ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE;

ALLELES; CLONE CELLS; EPITOPES; GRAFT REJECTION; HLA-DR ANTIGENS; HUMAN; IMMUNIZATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0027278656     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.6.1643     Document Type: Article

References (26)

1. Marrack, P., and J. Kappler. 1986. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature (Lond.). 322:840.
2. Matis, L.A., S.B. Sorger, D.L. McElligott, P.J. Fink, and S.M. Hedrick. 1987. The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Ceil 51:59.
3. Bevan, M.J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today. 5:128.
4. Lechler, R.I., G. Lombardi, J.R. Batchelor, N. Reinsmoen, and F.H. Bach. 1990. The molecular basis of alloreactivity. Immunol. Today. 11:83.
5. Sprent, J., M. Schaeter, D. Lo, and R. Korngold. 1986. Properties of purified T cell subsets. II. In vivo responses to class I vs class II H2 differences. J. Exp. Med. 163:998.
6. Rosenberg, A.S., T. Mizuochi, S.O. Sharrow, and A. Singer. 1987. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165:1296.
7. Ichikawa, T., E. Nakayama, A. Uenaka, M. Monden, and T. Mori. 1987. Effector cells in allelic H2 class I-incompatible skin graft rejection. J. Exp. Med. 166:982.
8. Rosenberg, A.S., T.I. Munitz, T.G. Maniero, and A. Singer. 1991. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8 + T cells in vivo. J. Exp Med. 173:1463.
9. Lombardi, G., S. Sidhu, J.R. Batchelor, and R.I. Lechler. 1989. Allorecognition of DR1 by T cells from a DR4/DRwl3 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA. 86:4190.
10. + T-cell dependent antibody-mediated graft rejection. Immunol. Today. 13:434.
11. Fangmann, J., R. Dalchau, and J.W. Fabre. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp Med. 175: 1521.
12. Benichou, G., P.A. Takizawa, C.A. Olson, M. McMillan, and E.E. Sercarz. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp Med. 175:305.
13. Liu, Z., N.S. Braunstein, and N. Suciu-Foca. 1992. T cell recognition of allopeptides in context of syngeneic MHC. J. Immunol. 148:35.
14. DeKoster, H.S., D.C. Anderson, and A. Termijtelen. 1989. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp Med. 169:1191.
15. Murphy, D.B., D. Lo, S. Rath, R.L. Brinster, R.A. Flavell, A. Slanetz, and C.A. Janeway, Jr. 1989. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature (Lond.). 338:765.
16. Rudensky, A.Y., S. Rath, P. Preston-Hurlburt, D.B. Murphy, and C.A. Janeway, Jr. 1991. On the complexity of self. Nature (Lond.). 353:660.
17. Suciu-Foca, N., E. Reed, V.D. D’Agati, E. Ho, D.J. Cohen, A.I. Benvenisty, R. McCabe, J.M. Brensilver, D.W. King, and M.A. Hardy. 1991. Soluble HLA-antigens, anti-HLA antibodies and anti-idiotypic antibodies in the circulation of renal transplant recipients. Transplantation (Baltimore). 51:594.
18. Suciu-Foca, N„ E. Reed, C. Marboe, Y.P. Xi, Y.K. Sun, E. Ho, E. Rose, K. Reemtsma, and D.W. King. 1991. Role of anti-HLA antibodies in heart transplantation. Transplantation (Baltimore). 51:716.
19. Reed, E., E. Ho, F. Lupu, P. McManus, R. Vasilescu, A. Foca-Rodi, and N. Suciu-Foca. 1992. Polymorphism of HLA in the Romanian population. Tissue Antigens. 39:8.
20. Harris, P., Z. Liu, and N. Suciu-Foca. 1992. MHC class II binding of peptides derived from HLA-DR1. J. Immunol. 148:2169.
21. Liu, Z., Y.K. Sun, Y.P. Xi, P. Harris, and N. Suciu-Foca. 1992. T cell recognition of self-human histocompatibility leucocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.J. Exp Med. 175:1663.
22. Chen, B.P., A. Madrigal, and P. Parham. 1990. Cytotoxic T cell recognition of an endogenous class IHLA peptide presented by a class II HLA molecule. J. Exp Med. 172:779.
23. Kievits, F., and P. Ivanyi. 1991. A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules. J. Exp Med. 174:15.
24. Benichou, G., P.A. Takizawa, P.T. Ho, C.C. Killion, C.A. Olson, M. McMillan, and E.E. Sercarz. 1990. Immunogenicity and tolerogencity of self-major histocompatibility complex peptides. J. Exp Med. 172:1341.
25. Bell, J.I., D. Denney, L. Foster, T. Belt, J.A. Todo, and H.O. McDevitt. 1987. Allelic variation in the DR subregion of the human major histocompatibility complex. Proc Natl Acad. Sac USA. 84:6234.
26. Burroughs, A.K., P. Butler, M.J.E. Sternberg, and H. Baum. 1992. Molecular mimicry in liver disease. Nature (Lond.). 358:377.